Drug Shortage Report for CIPROFLOXACIN
| Report ID | 138161 |
| Drug Identification Number | 02353318 |
| Brand name | CIPROFLOXACIN |
| Common or Proper name | CIPROFLOXACIN |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2021-09-12 |
| Actual start date | 2021-09-12 |
| Estimated end date | 2021-12-06 |
| Actual end date | 2021-12-06 |
| Shortage status | Resolved |
| Updated date | 2021-12-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.